Astrazeneca announces results from a sub-analysis of PLATO;
AstraZeneca announced results from a sub-analysis of PLATO that evaluated the effects of age on clinical outcomes in patients with acute coronary syndrome.
AstraZeneca PLC on Monday reported a positive result in a Phase III study of its thyroid cancer drug.